Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

Hypertension 2025: New Guidelines and Resistant Hypertension

University of Louisville

K. Ferdinand

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

Heart Failure in Women: 2025 Update

Scripps Health

M. Kittleson

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

Top 5 Arrhythmias You Need to Know

Joel Gorfinkel

Visceral Organ Doppler: A "Portal" to Volume Status

The Texas Heart Institute

M. Senussi

ACC 2025 Insights: Cardiac Function, Clinical Outcomes and Effect of…

ACC 2025 Insights

K. Jering

Pregnancy and CVD: The Role of Cardio‐Obstetrics in 2025

Scripps Health

A. Faksh, P. Uddin

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

AHA 2022 Conference Coverage

R. Mentz

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

Michelle Kittleson

PET Imagining in Cardiac Amyloidosis

NYU Langone

S. Dorbala

Chest Pain in Emergency Department Settings

University Hospitals

G. Rao, R. Hughes